Artykuły w czasopismach na temat „Prophylactic treatment of diarrhoea”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Prophylactic treatment of diarrhoea”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Bharadwaj, Shruthi Kumar, Sheila Samanta Mathai, Smriti Bhargava, and Leslie Edward S. Lewis. "Chronic diarrhoea due to trichohepatoenteric syndrome (THES) in an infant." BMJ Case Reports 17, no. 2 (2024): e257746. http://dx.doi.org/10.1136/bcr-2023-257746.
Pełny tekst źródłaDiemert, David J. "Prevention and Self-Treatment of Traveler's Diarrhea." Clinical Microbiology Reviews 19, no. 3 (2006): 583–94. http://dx.doi.org/10.1128/cmr.00052-05.
Pełny tekst źródłaJamil, Muhammad Omer, Maira Rizwan, and John T. Carpenter. "Prophylactic use of antidiarrheal agents to control diarrhea associated with lapatinib therapy in breast cancer patients." Journal of Clinical Oncology 33, no. 29_suppl (2015): 205. http://dx.doi.org/10.1200/jco.2015.33.29_suppl.205.
Pełny tekst źródłaHarder, Helena, Valerie M. Shilling, Shirley F. May, David Cella, Peter Schmid, and Lesley J. Fallowfield. "The development and initial evaluation of the Diarrhoea Management Diary (DMD) in patients with metastatic breast cancer." Breast Cancer Research and Treatment 183, no. 3 (2020): 629–38. http://dx.doi.org/10.1007/s10549-020-05798-w.
Pełny tekst źródłaTimko, Jaroslav. "Probiotics as prevention of radiation-induced diarrhoea." Journal of Radiotherapy in Practice 9, no. 4 (2010): 201–8. http://dx.doi.org/10.1017/s1460396910000087.
Pełny tekst źródłaBonafede, Machaon, Kathleen Wilson, and Fei Xue. "Long-term treatment patterns of prophylactic and acute migraine medications and incidence of opioid-related adverse events in patients with migraine." Cephalalgia 39, no. 9 (2019): 1086–98. http://dx.doi.org/10.1177/0333102419835465.
Pełny tekst źródłaIslam, Dilara, Nattaya Ruamsap, Rawiwan Imerbsin, et al. "Bioactivity and efficacy of a hyperimmune bovine colostrum product- Travelan, against shigellosis in a non-Human primate model (Macaca mulatta)." PLOS ONE 18, no. 12 (2023): e0294021. http://dx.doi.org/10.1371/journal.pone.0294021.
Pełny tekst źródłaGorelov, A. V., Е. V. Kanner, M. L. Maximov, A. S. Ermolaeva, A. A. Voznesenskaya, and K. N. Dadasheva. "Lactobacillus rhamnosus GG: clinical aspects of the use from the perspective of evidence-based medicine." Medical Council, no. 17 (October 22, 2018): 66–73. http://dx.doi.org/10.21518/2079-701x-2018-17-66-73.
Pełny tekst źródłaNield, Blake, Stephen R. Larsen, and Sebastiaan J. van Hal. "Clinical experience with new formulation SUBA®-itraconazole for prophylaxis in patients undergoing stem cell transplantation or treatment for haematological malignancies." Journal of Antimicrobial Chemotherapy 74, no. 10 (2019): 3049–55. http://dx.doi.org/10.1093/jac/dkz303.
Pełny tekst źródłaMathijssen, R. H., F. A. De Jong, D. F. Kehrer, et al. "Prophylactic treatment of irinotecan-induced diarrhea with neomycin (a randomized, placebo-controlled, double-blind study)." Journal of Clinical Oncology 24, no. 18_suppl (2006): 3626. http://dx.doi.org/10.1200/jco.2006.24.18_suppl.3626.
Pełny tekst źródłaT. K. Boranbayeva, Zh. K.Tulemissova, S. Ozkaya, and D. M. Khussainov. "EFFECT OF PROBIOTIC "LACTOBACTERIN-TK2" ON IMMUNOBIOLOGICAL STATUS OF NEWBORN CALVES IN THE THERAPEUTIC AND PROPHYLACTIC OF GASTROINTESTINAL DISEASES." BULLETIN 1, no. 383 (2020): 26–32. http://dx.doi.org/10.32014/2020.2518-1467.3.
Pełny tekst źródłaValpotić, Hrvoje, Davor Svoboda, Daniel Špoljarić, et al. "Evaluation of the prophylactic potential of non-enterotoxigenic Escherichia coli (non-ETEC) vaccine immunization and dietary mannan oligosaccharide competitive exclusion benefits against ETEC infections in weaned pigs." Veterinarski arhiv 92, no. 1 (2022): 53–72. http://dx.doi.org/10.24099/vet.arhiv.1584.
Pełny tekst źródłaFleming, Derek, Yuli Jiang, Kwaku Opoku, et al. "Prophylactic Probiotics in Burn Patients: Risk versus Reward." Journal of Burn Care & Research 40, no. 6 (2019): 953–60. http://dx.doi.org/10.1093/jbcr/irz132.
Pełny tekst źródłaMaggio, Angelo, Tiziana Rancati, Marco Gatti, et al. "Quality of Life Longitudinal Evaluation in Prostate Cancer Patients from Radiotherapy Start to 5 Years after IMRT-IGRT." Current Oncology 31, no. 2 (2024): 839–48. http://dx.doi.org/10.3390/curroncol31020062.
Pełny tekst źródłaClement, Dominique, John Ramage, and Raj Srirajaskanthan. "Update on Pathophysiology, Treatment, and Complications of Carcinoid Syndrome." Journal of Oncology 2020 (January 21, 2020): 1–11. http://dx.doi.org/10.1155/2020/8341426.
Pełny tekst źródłaAlvim, L. B., S. H. C. Sandes, B. C. Silva, et al. "Weissella paramesenteroides WpK4 reduces gene expression of intestinal cytokines, and hepatic and splenic injuries in a murine model of typhoid fever." Beneficial Microbes 7, no. 1 (2016): 61–73. http://dx.doi.org/10.3920/bm2015.0093.
Pełny tekst źródłaAl-Ghamdi, Hamed Saeed, Abdulrahman Hamza Altokhy, Nawal Hussain Bin Jalalah, et al. "Prophylaxis, diagnosis, and treatment of Traveler’s diarrhea." International Journal Of Community Medicine And Public Health 8, no. 12 (2021): 6071. http://dx.doi.org/10.18203/2394-6040.ijcmph20214438.
Pełny tekst źródłaPfaffenrath, V., P. Wessely, C. Meyer, et al. "Magnesium in the Prophylaxis of Migraine—a Double-Blind, Placebo-Controlled Study." Cephalalgia 16, no. 6 (1996): 436–40. http://dx.doi.org/10.1046/j.1468-2982.1996.1606436.x.
Pełny tekst źródłaCrown, John, Denis M. Collins, Alex J. Eustace, et al. "Abstract P1-11-09: Five year follow up of a randomized phase II comparison of neo-adjuvant docetaxel, carboplatin, trastuzumab with or without lapatinib in HER-2 positive breast cancer." Cancer Research 83, no. 5_Supplement (2023): P1–11–09—P1–11–09. http://dx.doi.org/10.1158/1538-7445.sabcs22-p1-11-09.
Pełny tekst źródłaTao, Heqing, Ligang Liu, Weipeng Lu, et al. "The Effects of Prophylactic Laxative Use on Critically Ill Patients Requiring Mechanical Ventilation: A Retrospective Cohort Study." Diseases 12, no. 11 (2024): 274. http://dx.doi.org/10.3390/diseases12110274.
Pełny tekst źródłada Silva Ferreira, Ana Rita, Hannah R. Wardill, Rick Havinga, Wim J. E. Tissing, and Hermie J. M. Harmsen. "Prophylactic Treatment with Vitamins C and B2 for Methotrexate-Induced Gastrointestinal Mucositis." Biomolecules 11, no. 1 (2020): 34. http://dx.doi.org/10.3390/biom11010034.
Pełny tekst źródłaCrown, John, Alex J. Eustace, Denis M. Collins, et al. "TCHL – a phase II neo-adjuvant study assessing TCH (docetaxel, carboplatin and trastuzumab) and TCHL (docetaxel, carboplatin, rastuzumab and lapatinib) in HER-2 positive breast cancer patients: a 5-year follow-up with serum biomarker analysis." Acta Oncologica 64 (June 5, 2025): 751–60. https://doi.org/10.2340/1651-226x.2025.43143.
Pełny tekst źródłaNisley, Mitchell J., Eric R. Burrough, Ben Haberl, et al. "12 Evaluation of pre-wean prophylactic anticoccidial and antimicrobial strategies." Journal of Animal Science 103, Supplement_1 (2025): 73. https://doi.org/10.1093/jas/skaf102.079.
Pełny tekst źródłaMecocci, Samanta, Livia De Paolis, Roberto Zoccola, et al. "Antimicrobial and Immunomodulatory Potential of Cow Colostrum Extracellular Vesicles (ColosEVs) in an Intestinal In Vitro Model." Biomedicines 10, no. 12 (2022): 3264. http://dx.doi.org/10.3390/biomedicines10123264.
Pełny tekst źródłaLeukhina, V. A. "Use experience of coniferous and phytogenic feed additives in treatment and prevention of eimeriosis in calves." Russian Journal of Parasitology 18, no. 1 (2024): 74–79. http://dx.doi.org/10.31016/1998-8435-2024-18-1-74-79.
Pełny tekst źródłaPérez García, José Manuel, María Gión, Manuel Ruiz-Borrego, et al. "Prevention of sacituzumab govitecan (SG)-related neutropenia and diarrhea in patients (pts) with triple-negative or HR+/HER2- advanced breast cancer (ABC; PRIMED): A phase 2 trial." Journal of Clinical Oncology 42, no. 16_suppl (2024): 1101. http://dx.doi.org/10.1200/jco.2024.42.16_suppl.1101.
Pełny tekst źródłaEcharri, María José, Marta Santisteban, and Juan David Cárdenas. "Abstract P1-06-12: Efficacy and safety of the addition of prophylactic atropine to patients with metastatic triple-negative breast cancer treated with sacituzumab govitecan: a Spanish multicenter real-world study." Clinical Cancer Research 31, no. 12_Supplement (2025): P1–06–12—P1–06–12. https://doi.org/10.1158/1557-3265.sabcs24-p1-06-12.
Pełny tekst źródłaHarp, James A., Phillip Jardon, E. Rob Atwill, et al. "Field testing of prophylactic measures against Cryptosporidium parvum infection in calves in a California dairy herd." American Journal of Veterinary Research 57, no. 11 (1996): 1586–88. http://dx.doi.org/10.2460/ajvr.1996.57.11.1586.
Pełny tekst źródłaFortuoso, Bruno F., Andreia Volpato, Luana Rampazzo, et al. "Homeopathic treatment as an alternative prophylactic to minimize bacterial infection and prevent neonatal diarrhea in calves." Microbial Pathogenesis 114 (January 2018): 95–98. http://dx.doi.org/10.1016/j.micpath.2017.11.041.
Pełny tekst źródłaGonzalez Maeso, Iria, Daniel E. Castellano, Begona Campos Balea, et al. "Meaningful survival after cabazitaxel in patients with metastatic castration-resistant prostate cancer (mCRPC): The Spanish experience." Journal of Clinical Oncology 32, no. 4_suppl (2014): 235. http://dx.doi.org/10.1200/jco.2014.32.4_suppl.235.
Pełny tekst źródłaCoelho, Cideli de Paula, Erlete Rosalina Vuaden, Francisco Rafael Martins Soto, et al. "Evaluation of homeopathic treatment of Escherichia coli infected swine with indetification of virulence factors involved: Pilot study." International Journal of High Dilution Research - ISSN 1982-6206 13, no. 49 (2021): 197–206. http://dx.doi.org/10.51910/ijhdr.v13i49.715.
Pełny tekst źródłaLeprêtre, Stephane, Frédéric Maloisel, Didier Kamioner, Christian Berthou, and Hélène Albrand. "Safety of Biosimilar Filgrastim in Patients Undergoing Neutropenia-Inducing Chemotherapy: The Next Study." Blood 124, no. 21 (2014): 4976. http://dx.doi.org/10.1182/blood.v124.21.4976.4976.
Pełny tekst źródłaGardner, Ian A., David W. Hird, Charles E. Franti, and John S. Glenn. "Randomized efficacy trials of long-acting oxytetracycline in neonatal pigs." Journal of the American Veterinary Medical Association 194, no. 5 (1989): 659–63. https://doi.org/10.2460/javma.1989.194.05.659.
Pełny tekst źródłaIkeda, Go, Akihiro Ohara, Mai Itoyama, et al. "Efficacy of prophylactic pegfilgrastim on day three of preoperative DCF chemotherapy in elderly patients with resectable esophageal cancer." Journal of Clinical Oncology 40, no. 4_suppl (2022): 305. http://dx.doi.org/10.1200/jco.2022.40.4_suppl.305.
Pełny tekst źródłaBarcenas, Carlos Hernando, Sara A. Hurvitz, Jack A. Di Palma, et al. "Effect of prophylaxis on neratinib-associated diarrhea and tolerability in patients with HER2+ early-stage breast cancer: Phase II CONTROL trial." Journal of Clinical Oncology 37, no. 15_suppl (2019): 548. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.548.
Pełny tekst źródłaBreitrück, Anne, Markus Weigel, Jacqueline Hofrichter, et al. "Smectite as a Preventive Oral Treatment to Reduce Clinical Symptoms of DSS Induced Colitis in Balb/c Mice." International Journal of Molecular Sciences 22, no. 16 (2021): 8699. http://dx.doi.org/10.3390/ijms22168699.
Pełny tekst źródłaMuhammad Salih and Maryam Qamar. "Prophylactic anti-emetic use to counter opioid adverse effects in the emergency department: Is it doing more harm than good?" Journal of the Pakistan Medical Association 73, no. 05 (2023): 1168. http://dx.doi.org/10.47391/jpma.7940.
Pełny tekst źródłaHuang, Jin-lin, Yan-Xin Yin, Zhi-ming Pan, et al. "Intranasal Immunization with Chitosan/pCAGGS-flaA Nanoparticles InhibitsCampylobacter jejuniin a White Leghorn Model." Journal of Biomedicine and Biotechnology 2010 (2010): 1–8. http://dx.doi.org/10.1155/2010/589476.
Pełny tekst źródłaTakahashi, Kazuo, Kazutaka Ohashi, Yurika Abe, et al. "Protective Efficacy of a Sulfated Sialyl Lipid (NMSO3) against Human Rotavirus-Induced Diarrhea in a Mouse Model." Antimicrobial Agents and Chemotherapy 46, no. 2 (2002): 420–24. http://dx.doi.org/10.1128/aac.46.2.420-424.2002.
Pełny tekst źródłaTutida, Y. H., J. H. Montes, K. K. Borstnez, et al. "Effects of in feed removal of antimicrobials in comparison to other prophylactic alternatives in growing and finishing pigs." Arquivo Brasileiro de Medicina Veterinária e Zootecnia 73, no. 6 (2021): 1381–90. http://dx.doi.org/10.1590/1678-4162-12450.
Pełny tekst źródłaPokharel, Pravil, Sabin Dhakal, and Charles M. Dozois. "The Diversity of Escherichia coli Pathotypes and Vaccination Strategies against This Versatile Bacterial Pathogen." Microorganisms 11, no. 2 (2023): 344. http://dx.doi.org/10.3390/microorganisms11020344.
Pełny tekst źródłaZhang, Jin, Haiguang Liu, Xinlan Liu, et al. "Abstract P5-07-19: A multicenter, prospective, non-interventional study to investigate the treatment patterns of neratinib in Human Epidermal Growth Factor Receptor 2 positive (HER2+) early breast cancer (EBC) in China: NER-Tree study—An interim analysis on safety." Clinical Cancer Research 31, no. 12_Supplement (2025): P5–07–19—P5–07–19. https://doi.org/10.1158/1557-3265.sabcs24-p5-07-19.
Pełny tekst źródłaGion, María, Manuel Ruiz-Borrego, Isabel Blancas, et al. "Abstract P1-02-06: Efficacy analysis & updated safety from the phase 2 PRIMED study of prophylactic granulocyte-colony stimulating factor (G-CSF) & loperamide for patients (pts) with HER2-negative advanced breast cancer (ABC) treated w/ sacituzumab govitecan (SG)." Clinical Cancer Research 31, no. 12_Supplement (2025): P1–02–06—P1–02–06. https://doi.org/10.1158/1557-3265.sabcs24-p1-02-06.
Pełny tekst źródłaMarathe, Omkar Subhash, Lina Tang, Robert C. Tyler, et al. "A survey study of prevention and treatment patterns by academic and community oncologists for cancer therapy-associated diarrhea." Journal of Clinical Oncology 40, no. 4_suppl (2022): 76. http://dx.doi.org/10.1200/jco.2022.40.4_suppl.076.
Pełny tekst źródłaWu, Ping, Wei Ling, Chengwei Luo Luo, et al. "MRD-Driven Prophylactic or Pre-Emptive Intervention with Chidamide-Based Treatment for High-Risk AML Relapse Post-Transplantation: A Real-World Experience from a Chinese Single Center." Blood 144, Supplement 1 (2024): 1575. https://doi.org/10.1182/blood-2024-210697.
Pełny tekst źródłaYerushalmi, Rinat, Salomon M. Stemmer, Daniel Hendler, et al. "Adjuvant docetaxel and cyclophosphamide (DC) with prophylactic growth colony stimulating factor (GCSF) on days 8 and 12 in breast cancer patients: A retrospective analysis." Journal of Clinical Oncology 30, no. 27_suppl (2012): 202. http://dx.doi.org/10.1200/jco.2012.30.27_suppl.202.
Pełny tekst źródłaBeketova, H. V., O. O. Koiro, S. S. Bohdanova, et al. "Efficacy of Bacillus clausii UBBC-07 in the prevention of antibiotic-associated diarrhea in children." CHILD`S HEALTH 19, no. 7 (2024): 454–63. https://doi.org/10.22141/2224-0551.19.7.2024.1758.
Pełny tekst źródłaKanazawa, Mimari, Takeshi Sugaya, Fumiaki Takahashi, et al. "A Case of Bilateral Acute Inferior Limb Ischemia in a Patient With Ulcerative Colitis." Clinical Medicine Insights: Case Reports 13 (January 2020): 117954762091273. http://dx.doi.org/10.1177/1179547620912734.
Pełny tekst źródłaCaputo, Roberta, Giuseppe Buono, Vincenzo Di Lauro, et al. "Neratinib as adjuvant therapy in patients with HER2 positive breast cancer: expert opinion." Future Oncology 19, no. 24 (2023): 1695–708. http://dx.doi.org/10.2217/fon-2023-0361.
Pełny tekst źródłaAlomari, Mohammed Mijbas M., Marta Dec, Anna Nowaczek, et al. "Therapeutic and Prophylactic Effect of the Experimental Bacteriophage Treatment to Control Diarrhea Caused by E. coli in Newborn Calves." ACS Infectious Diseases 7, no. 8 (2021): 2093–101. http://dx.doi.org/10.1021/acsinfecdis.1c00010.
Pełny tekst źródła